Skip to main content

The Quantity and Quality of Surgical Trials in Pancreatic Cancer

  • Chapter
  • First Online:
Textbook of Pancreatic Cancer

Abstract

Randomized controlled trials represent the foundation for evidence-based decision making in clinical practice. However, especially in complex surgical areas such as pancreatic cancer surgery, high quality evidence from surgical randomized controlled trials was usually scarce. In recent years both, the quantity as well as the quality of surgical trials focusing on pancreatic cancer have increased. Nevertheless, there are still evidence gaps regarding specific issues of surgical treatment of pancreatic cancer. Shortcomings remain in trial methodology and reporting for individual domains such as blinding and selective reporting. Novel methods, including priority setting partnerships and evidence mapping, could help to identify and prioritize the most patient-relevant research questions that need to be answered by collaborative research projects with bundled forces in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, et al. Challenges in evaluating surgical innovation. Lancet. 2009;374(9695):1097–104. https://doi.org/10.1016/S0140-6736(09)61086-2.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hüttner FJ, Doerr-Harim C, Probst P, Tenckhoff S, Knebel P, Diener MK. Study methods in evidence-based surgery: methodological impediments and suggested approaches for the creation and transfer of knowledge in surgery. Eur Surg Res. 2014;53(1–4):86–94. https://doi.org/10.1159/000366201.

    Article  PubMed  Google Scholar 

  3. Doerr-Harim C, Bruckner T, Diener MK, Knebel P. Insights into surgical trials: methodological challenges and solutions. Langenbeck's Arch Surg. 2014;399(3):273–8. https://doi.org/10.1007/s00423-013-1155-5.

    Article  Google Scholar 

  4. Probst P, Grummich K, Harnoss JC, Hüttner FJ, Jensen K, Braun S, et al. Placebo-controlled trials in surgery: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(17):e3516. https://doi.org/10.1097/MD.0000000000003516.

    Article  CAS  Google Scholar 

  5. Shawhan RR, Hatch QM, Bingham JR, Nelson DW, Fitzpatrick EB, McLeod R, et al. Have we progressed in the surgical literature? Thirty-year trends in clinical studies in 3 surgical journals. Dis Colon Rectum. 2015;58(1):115–21. https://doi.org/10.1097/DCR.0000000000000273.

    Article  PubMed  Google Scholar 

  6. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery. 1994;115(6):707–12.

    CAS  PubMed  Google Scholar 

  7. Wente MN, Seiler CM, Uhl W, Buchler MW. Perspectives of evidence-based surgery. Dig Surg. 2003;20(4):263–9. https://doi.org/10.1159/000071183.

    Article  PubMed  Google Scholar 

  8. McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105–12. https://doi.org/10.1016/S0140-6736(09)61116-8.

    Article  PubMed  Google Scholar 

  9. Dutch Pancreatic Cancer Group. http://www.dpcg.nl. Accessed 26 Oct 2019.

  10. Probst P, Klaiber U, Hüttner F, Doerr-Harim C, Knebel P, Rossion I et al. [Evidence-based surgery—the Study Center of the German Surgical Society]. Z Evid Fortbild Qual Gesundhwes. 2015;109(3):199–210. doi:https://doi.org/10.1016/j.zefq.2015.03.001.

  11. McCulloch P, Feinberg J, Philippou Y, Kolias A, Kehoe S, Lancaster G, et al. Progress in clinical research in surgery and IDEAL. Lancet. 2018;392(10141):88–94. https://doi.org/10.1016/S0140-6736(18)30102-8.

    Article  PubMed  Google Scholar 

  12. Hüttner FJ, Capdeville L, Pianka F, Ulrich A, Hackert T, Büchler MW, et al. Systematic review of the quantity and quality of randomized clinical trials in pancreatic surgery. Br J Surg. 2019;106(1):23–31. https://doi.org/10.1002/bjs.11030.

    Article  PubMed  Google Scholar 

  13. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147–56. https://doi.org/10.1001/jama.2012.7352.

    Article  CAS  PubMed  Google Scholar 

  14. Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011–24. https://doi.org/10.1016/S0140-6736(16)32409-6.

    Article  CAS  PubMed  Google Scholar 

  15. Bornman PC, Harries-Jones EP, Tobias R, Van Stiegmann G, Terblanche J. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet. 1986;1(8472):69–71. https://doi.org/10.1016/s0140-6736(86)90719-1.

    Article  CAS  PubMed  Google Scholar 

  16. Gullichsen R, Havia T, Ovaska J, Rantala A. Cholecystoenteral anastomosis with the biofragmentable ring and manual suture—a prospective, randomized study. Ann Chir Gynaecol. 1992;81(4):354–6.

    CAS  PubMed  Google Scholar 

  17. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228(4):508–17. https://doi.org/10.1097/00000658-199810000-00007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Di Carlo V, Gianotti L, Balzano G, Zerbi A, Braga M. Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg. 1999;16(4):320–6. https://doi.org/10.1159/000018742.

    Article  PubMed  Google Scholar 

  19. Yilmaz S, Kirimlioglu V, Katz DA, Kayaalp C, Caglikulekci M, Ara C. Randomised clinical trial of two bypass operations for unresectable cancer of the pancreatic head. Eur J Surg. 2001;167(10):770–6. https://doi.org/10.1080/11024150152707761.

    Article  CAS  PubMed  Google Scholar 

  20. Lygidakis NJ, Sgourakis G, Georgia D, Vlachos L, Raptis S. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study. Ann Surg. 2002;236(6):806–13. https://doi.org/10.1097/00000658-200212000-00013.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, et al. Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study. Hepato-Gastroenterology. 2004;51(56):427–33.

    CAS  PubMed  Google Scholar 

  22. Slotwinski R, Olszewski WL, Slotkowski M, Lech G, Zaleska M, Slotwinska SM, et al. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy? JOP. 2007;8(6):759–69.

    PubMed  Google Scholar 

  23. Uggeri F, Caprotti R, De Grate L, Crippa S, Nobili C, Penati C, et al. Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study. Hepato-Gastroenterology. 2009;56(91–92):861–5.

    CAS  PubMed  Google Scholar 

  24. Slotwinski R, Olszewski W, Slodkowski M, Lech G, Zaleska M, Kedziora S, et al. Apoptosis in lymphocytes of pancreatic cancer patients: influence of preoperative enteral immunonutrition and extensive surgery. Arch Immunol Ther Exp. 2011;59(5):385–97. https://doi.org/10.1007/s00005-011-0140-3.

    Article  CAS  Google Scholar 

  25. Szymanski D, Durczynski A, Nowicki M, Strzelczyk J. Gastrojejunostomy in patients with unresectable pancreatic head cancer—the use of Roux loop significantly shortens the hospital length of stay. World J Gastroenterol. 2013;19(45):8321–5. https://doi.org/10.3748/wjg.v19.i45.8321.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bjersa K, Andersson T. High frequency TENS as a complement for pain relief in postoperative transition from epidural to general analgesia after pancreatic resection. Complement Ther Clin Pract. 2014;20(1):5–10. https://doi.org/10.1016/j.ctcp.2013.11.004.

    Article  PubMed  Google Scholar 

  27. Gall TM, Jacob J, Frampton AE, Krell J, Kyriakides C, Castellano L, et al. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg. 2014;149(5):482–5. https://doi.org/10.1001/jamasurg.2013.3643.

    Article  PubMed  Google Scholar 

  28. Gade J, Levring T, Hillingso J, Hansen CP, Andersen JR. The effect of preoperative oral immunonutrition on complications and length of hospital stay after elective surgery for pancreatic cancer—a randomized controlled trial. Nutr Cancer. 2016;68(2):225–33. https://doi.org/10.1080/01635581.2016.1142586.

    Article  PubMed  Google Scholar 

  29. Ignjatovic I, Knezevic S, Knezevic D, Dugalic V, Micev M, Matic S, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma. J BUON. 2017;22(1):232–8.

    PubMed  Google Scholar 

  30. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg. 1999;86(5):603–7. https://doi.org/10.1046/j.1365-2168.1999.01074.x.

    Article  CAS  PubMed  Google Scholar 

  31. Imamura M, Doi R, Imaizumi T, Funakoshi A, Wakasugi H, Sunamura M, et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery. 2004;136(5):1003–11. https://doi.org/10.1016/j.surg.2004.04.030.

    Article  PubMed  Google Scholar 

  32. Tian FZ, Shi L, Tang LJ, Wang T, Li DX, Zou S, et al. [Perspective of pre-operational jaundice-reducing indication in carcinoma of head of pancreas]. Zhonghua Wai Ke Za Zhi. 2006;44(23):1614–6.

    Google Scholar 

  33. Nimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, et al. Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci. 2012;19(3):230–41. https://doi.org/10.1007/s00534-011-0466-6.

    Article  PubMed  Google Scholar 

  34. Guo JC, Li J, Hu Y, Zhang TP, Liao Q, Dai MH, et al. [The role of perioperative enteral and parenteral nutrition treatment in pancreatic cancer: a multicenter, prospective randomized controlled trial]. Zhonghua Wai Ke Za Zhi. 2013;51(11):987–90.

    Google Scholar 

  35. Jang JY, Kang MJ, Heo JS, Choi SH, Choi DW, Park SJ, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer. Ann Surg. 2014;259(4):656–64. https://doi.org/10.1097/SLA.0000000000000384.

    Article  PubMed  Google Scholar 

  36. Reyad AR, Elkharboutly W, Wahba A, Elmorshedi M, Hasaneen NA. Effect of intraoperative dobutamine on splanchnic tissue perfusion and outcome after Whipple surgery. J Crit Care. 2013;28(4):531.e7–15. https://doi.org/10.1016/j.jcrc.2013.02.017.

    Article  CAS  Google Scholar 

  37. Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, Dahl TR, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery. 2005;138(4):618–28.; ; discussion 28–30. https://doi.org/10.1016/j.surg.2005.06.044.

    Article  PubMed  Google Scholar 

  38. Artifon EL, Sakai P, Cunha JE, Dupont A, Filho FM, Hondo FY, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol. 2006;101(9):2031–7. https://doi.org/10.1111/j.1572-0241.2006.00764.x.

    Article  PubMed  Google Scholar 

  39. Brooke BS, Nathan H, Pawlik TM. Trends in the quality of highly cited surgical research over the past 20 years. Ann Surg. 2009;249(1):162–7. https://doi.org/10.1097/SLA.0b013e31819291f9.

    Article  PubMed  Google Scholar 

  40. Ahmed Ali U, van der Sluis PC, Issa Y, Habaga IA, Gooszen HG, Flum DR, et al. Trends in worldwide volume and methodological quality of surgical randomized controlled trials. Ann Surg. 2013;258(2):199–207. https://doi.org/10.1097/SLA.0b013e31829c7795.

    Article  PubMed  Google Scholar 

  41. Antoniou SA, Andreou A, Antoniou GA, Koch OO, Kohler G, Luketina RR, et al. Volume and methodological quality of randomized controlled trials in laparoscopic surgery: assessment over a 10-year period. Am J Surg. 2015;210(5):922–9. https://doi.org/10.1016/j.amjsurg.2015.04.022.

    Article  PubMed  Google Scholar 

  42. Chapman SJ, Aldaffaa M, Downey CL, Jayne DG. Research waste in surgical randomized controlled trials. Br J Surg. 2019;106(11):1464–71. https://doi.org/10.1002/bjs.11266.

    Article  CAS  PubMed  Google Scholar 

  43. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, et al. Biomedical research: increasing value, reducing waste. Lancet. 2014;383(9912):101–4. https://doi.org/10.1016/S0140-6736(13)62329-6.

    Article  PubMed  Google Scholar 

  44. Staley K, Crowe S. More than a top 10: how James Lind Alliance priority setting partnerships transform research, people and organisations; 2019.

    Google Scholar 

  45. Probst P, Hüttner FJ, Meydan O, Kalkum E, Kretschmer R, Jensen K, et al. Evidence map of pancreatic surgery: protocol for a living systematic review and meta-analysis. BMJ Open. 2019;9(9):e032353. https://doi.org/10.1136/bmjopen-2019-032353.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Goere D, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v56–68. https://doi.org/10.1093/annonc/mdv295.

    Article  PubMed  Google Scholar 

  47. Diener MK, Hüttner FJ, Kieser M, Knebel P, Dorr-Harim C, Distler M, et al. Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial. Lancet. 2017;390(10099):1027–37. https://doi.org/10.1016/S0140-6736(17)31960-8.

    Article  PubMed  Google Scholar 

  48. Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011;377(9776):1514–22. https://doi.org/10.1016/S0140-6736(11)60237-7.

    Article  PubMed  Google Scholar 

  49. Reynolds T. Why randomized surgical oncology trials are so scarce. J Natl Cancer Inst. 1999;91(14):1182–3. https://doi.org/10.1093/jnci/91.14.1182.

    Article  CAS  PubMed  Google Scholar 

  50. Shore BJ, Nasreddine AY, Kocher MS. Overcoming the funding challenge: the cost of randomized controlled trials in the next decade. J Bone Joint Surg Am. 2012;94(Suppl 1):101–6. https://doi.org/10.2106/JBJS.L.00193.

    Article  PubMed  Google Scholar 

  51. Forrester JA, Forrester JD, Wren SM. Trends in country-specific surgical randomized clinical trial publications. JAMA Surg. 2018;153(4):386–8. https://doi.org/10.1001/jamasurg.2017.4867.

    Article  PubMed  Google Scholar 

  52. Probst P, Zaschke S, Heger P, Harnoss JC, Hüttner FJ, Mihaljevic AL, et al. Evidence-based recommendations for blinding in surgical trials. Langenbeck's Arch Surg. 2019;404(3):273–84. https://doi.org/10.1007/s00423-019-01761-6.

    Article  Google Scholar 

  53. Rosenthal R, Dwan K. Comparison of randomized controlled trial registry entries and content of reports in surgery journals. Ann Surg. 2013;257(6):1007–15. https://doi.org/10.1097/SLA.0b013e318283cf7f.

    Article  PubMed  Google Scholar 

  54. Oberkofler CE, Hamming JF, Staiger RD, Brosi P, Biondo S, Farges O, et al. Procedural surgical RCTs in daily practice: do surgeons adopt or is it just a waste of time? Ann Surg. 2019;270(5):727–34. https://doi.org/10.1097/SLA.0000000000003546.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Markus K. Diener .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hüttner, F.J., Probst, P., Diener, M.K. (2021). The Quantity and Quality of Surgical Trials in Pancreatic Cancer. In: Søreide, K., Stättner, S. (eds) Textbook of Pancreatic Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-53786-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53786-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53785-2

  • Online ISBN: 978-3-030-53786-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics